| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | Jul 30, 2025 | ImageneBio, Inc. | Director | Buy | 100.0 | +83,611 | 12.25% | ✗ | $2.5M |
| May 22, 2023 | May 24, 2023 | Prelude Therapeutics Inc | Director | Buy | 95.0 | +869,565 | 9.40% | ✗ | $5M |
| Jun 22, 2022 | Jun 24, 2022 | ImageneBio, Inc. | Director | Sell | 17.5 | -252,225 | -1.83% | ✗ | $1.1M |
| Sep 3, 2021 | Sep 8, 2021 | Repare Therapeutics Inc. | Director | Sell | 47.5 | -8,084 | -0.12% | ✓ | $274.8K |
| Aug 31, 2021 | Sep 2, 2021 | Repare Therapeutics Inc. | Director | Sell | 43.8 | -37,864 | -0.38% | ✓ | $1.3M |
| Aug 26, 2021 | Aug 30, 2021 | Repare Therapeutics Inc. | Director | Sell | 47.5 | -18,073 | -0.18% | ✓ | $615.7K |
| Aug 23, 2021 | Aug 25, 2021 | Repare Therapeutics Inc. | Director | Sell | 47.5 | -18,215 | -0.18% | ✓ | $622.4K |
| Aug 17, 2021 | Aug 25, 2021 | Repare Therapeutics Inc. | Director | Sell | 46.3 | -20,328 | -0.30% | ✓ | $693.2K |
| Aug 17, 2021 | Aug 19, 2021 | Repare Therapeutics Inc. | Director | Sell | 46.3 | -20,328 | -0.30% | ✓ | $693.2K |
| Jul 16, 2021 | Jul 23, 2021 | Enliven Therapeutics, Inc. | Director | Buy | 100.0 | +1,666,666 | 65.81% | ✗ | $10M |
| Jul 16, 2021 | Jul 16, 2021 | Enliven Therapeutics, Inc. | Director | Buy | 100.0 | +1,666,666 | 100.00% | ✗ | $10M |
| Mar 30, 2021 | Apr 14, 2021 | ImageneBio, Inc. | Director | Buy | 100.0 | +423,400 | 27.98% | ✗ | $6.8M |
| Mar 30, 2021 | Apr 1, 2021 | ImageneBio, Inc. | Director | Buy | 100.0 | +423,400 | 22.46% | ✗ | $6.8M |
| Sep 25, 2020 | Sep 30, 2020 | Prelude Therapeutics Inc | Director | Buy | 100.0 | +1,236,800 | 597.74% | ✗ | $23.5M |
| Jun 23, 2020 | Jun 25, 2020 | Repare Therapeutics Inc. | Director | Buy | 100.0 | +774,200 | 29.76% | ✗ | $15.5M |
| Mar 12, 2020 | Mar 16, 2020 | Enliven Therapeutics, Inc. | Director | Buy | 100.0 | +937,500 | 100.00% | ✗ | $15M |
| Oct 19, 2018 | Oct 19, 2018 | SI-BONE, Inc. | Director | Buy | 100.0 | +200,000 | 25.47% | ✗ | $3M |